NCT05873231 Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
| NCT ID | NCT05873231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-04-28 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2021-04-28 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The role of the gut microbiome in the development of side effects of anti cancer treatment will be assessed in this longitudinal cohort study.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Start of a systemic anti-cancer therapy * Informed consent Exclusion Criteria: * • Pre-existing diarrhoea * Antibiotic therapy -4 to -1 week before inclusion * Probiotic treatment -4 to -1 week before inclusion * Inability to give informed consent
Frequently Asked Questions
Who can join the NCT05873231 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05873231 currently recruiting?
Yes, NCT05873231 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medical University of Graz to inquire about joining.
Where is the NCT05873231 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT05873231 clinical trial?
NCT05873231 is sponsored by Medical University of Graz. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.